Library — CHDR

Search

Filter

Interaction study between nifedipine and recombinant tissue-type plasminogen activator in healthy subjects.

De Boer A, Kluft C, Kasper FJ, Kroon JM, Schoemaker HC, Breimer DD, Soons PA, Cohen AF

British journal of clinical pharmacology, 1993 Jul; 36(2):99-104

View publication
Cimetidine does not influence the metabolism of the H1-receptor antagonist ebastine to its active metabolite carebastine.

Van Rooij J, Schoemaker HC, Bruno R, Reinhoudt JF, Breimer DD, Cohen AF

British journal of clinical pharmacology, 1993 May; 35(6):661-3

View publication
The pharmacokinetic and pharmacodynamic interactions of ramipril with propranolol.

van Griensven JM, Seibert-Grafe M, Schoemaker HC, Frölich M, Cohen AF

European journal of clinical pharmacology, 1993 Apr; 45(3):255-60

View publication
Stereoselective pharmacokinetics of oral felodipine and nitrendipine in healthy subjects: correlation with nifedipine pharmacokinetics.

Soons PA, Mulders TM, Uchida E, Schoemaker HC, Cohen AF, Breimer DD

European journal of clinical pharmacology, 1993 Apr; 44(2):163-9

View publication
CNS-related performance and haemodynamics of metoprolol-Oros and propranolol after single and 3 days dosing in healthy volunteers.

van Steveninck AL, Pieters MS, Schoemaker HC, Breimer DD, Cohen AF

British journal of clinical pharmacology, 1993 Jan; 35(2):114-20

View publication
The bioavailability of digoxin from three oral formulations measured by a specific h.p.l.c. assay.

Cohen AF, Kroon R, Schoemaker HC, Breimer DD, Van Vliet-Verbeek A, Brandenburg HC

British journal of clinical pharmacology, 1993 Jan; 35(2):136-42

View publication
Influence of heparin and a low molecular weight heparinoid on specific endogenous and exogenous fibrinolytic factors during rest and exercise.

de Boer A, Kluft C, Dooijewaard G, Kasper FJ, Kroon JM, Breimer DD, Stiekema JC, Cohen AF

Thrombosis and haemostasis, 1992 Nov; 68(5):550-5

View publication
Highly variable anticoagulant response after subcutaneous administration of high-dose (12,500 IU) heparin in patients with myocardial infarction and healthy volunteers.

Kroon C, ten Hove WR, de Boer A, Kroon JM, van der Pol JM, Harthoorn-Lasthuizen EJ, Schoemaker HC, van der Meer FJ, Cohen AF

Circulation, 1992 Oct; 86(5):1370-5

View publication
Diurnal rhythm in anticoagulant effect of heparin during a low dose constant rate infusion. A study in healthy volunteers.

Krulder JW, de Boer A, van den Besselaar AM, Cohen AF, Schoemaker HC, Briët E, Meinders AE

Thrombosis and haemostasis, 1992 Jul; 68(1):30-2

View publication

«
1
2
3
4
5
6
7
8
»